5 reports

  • Gene Therapy for Hemophilia B and Inherited Blindness
  • Top Inventors Gene Therapy for Hemophilia B Company

Global Gene Therapy Market Report-2026 July 2018 List of Figures List of Tables ##.

  • Gene Therapy
  • Therapy
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Sangamo BioSciences, Inc.
  • GENE THERAPY LANDSCAPE, OVERVIEW OF KEY PIPELINE PRODUCTS IN HEMOPHILIA B
  • PIPELINE PRODUCTS COVERED

Advances in Cell and Gene Therapy, ##(##), e##.

  • Gene Therapy
  • Medical Biotechnology
  • Therapy
  • Casebia Therapeutics LLP
  • Sangamo BioSciences, Inc.

Gene therapy restores telomerase enzyme.

  • Cancer
  • Gene Therapy
  • Lung Cancer
  • Therapy
  • Geron Corporation
  • Jan 05, 2017: Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A
  • 08/25/2017: Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 Investigational Gene Therapy For Hemophilia A

Gene therapy holds promise as a potential one-time treatment to control Hemophilia A and prevent spontaneous bleeding, " said Dr.

  • Blood Disease
  • Gene Therapy
  • Pharmaceutical
  • Therapy
  • Sangamo BioSciences, Inc.
  • SANGAMO BIOSCIENCES, INC. - DISCOVERY, 2016
  • SANGAMO BIOSCIENCES, INC. - PRECLINICAL, 2016

Licensing and Collaboration GENE THERAPY TO ACTIVATE ALPHA-## ANTITRYPSIN FOR ALPHA-ANTITRYPSIN DEFICIENCY ZFN-corrected iPSCs (induced pluripotent stem cells) is under development for the treatment of alpha ##-antitrypsin deficiency.

  • Blood Disease
  • Gene Therapy
  • Research And Development
  • Therapy
  • Sangamo BioSciences, Inc.